Quantcast

Tag Archives: Pharmaceutical

A game-changing challenge? (access required)

In late December, Circuit Court Judge Roger Couch finalized a $327 million verdict against pharmaceutical giant Johnson & Johnson for the way it marketed its antipsychotic drug, Risperdal. On or about the same day, he also gave another drug maker, AstraZeneca Pharmaceutical, the green light to move forward with a challenge to South Carolina’s action against the company for the marketing of its own antipsychotic drug, Seroquel, on the grounds that the state attorney general’s office had compromised its independence in pursuing the case.

Read More »

Bill: FDA approval would bar drug liability claims (access required)

In what plaintiffs' lawyers are calling a "radical" move, House Republicans are pushing for a measure that would give immunity in products-liability cases to pharmaceutical manufacturers so long as a drug was approved by the Federal Drug Administration. The provision says that no manufacturer or seller shall be held liable in a products-liability action so long as the product was designed, manufactured, packaged and sold in accordance with the terms of an approval of a government agency.

Read More »

Novartis hit with nearly $13M verdict in failure-to-warn case (access required)

A federal jury in Winston-Salem has returned a verdict of nearly $13 million against pharmaceutical giant Novartis, saying the company failed to adequately warn patients and doctors about the risks of taking the bone-strengthening drugs Zometa and Aredia. The estate of Rita Fussman of Chapel Hill had sued Novartis after Fussman came down with what at first appeared to be a mysterious jaw disease after she had been taking the drugs for several years. Fussman discovered her complications with the drug when she had a CT scan on her jaw. "The guy said, ‘You have exposed bone in your mouth,'" said Vernon Glenn (pictured) of Winston-Salem, a second-chair attorney for Fussman.

Read More »